China Pharma Holdings (CPHI) Other Working Capital Changes (2013 - 2014)
China Pharma Holdings (CPHI) posted Other Working Capital Changes of -$51376.0 for Q1 2026, down 6.99% on a QoQ basis from -$48019.0 in Q1 2025, and down 6.99% year-over-year from -$55237.7 in Q1 2025.
China Pharma Holdings (CPHI) Other Working Capital Changes (2013 - 2014) Analysis & Trends
China Pharma Holdings' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$51376.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 6.99% year-over-year to -$51376.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36821.0 (down 1091.14% YoY) and the FY2025 annual result came in at -$53444.0, down 172.5% from the prior year.
- Other Working Capital Changes was -$51376.0 for Q1 2026 at China Pharma Holdings, down from -$48019.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.0 million in Q4 2014 and bottomed at -$1.9 million in Q3 2014.
- A 5-year average of -$7805.8 and a median of -$48471.5 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 342.39% in 2023, while the deepest fall reached 688.77% in 2023.
- China Pharma Holdings' Other Working Capital Changes stood at $452021.0 in 2022, then sank by 118.33% to -$82849.0 in 2023, then jumped by 268.16% to $139322.0 in 2024, then tumbled by 134.47% to -$48019.0 in 2025, then slipped by 6.99% to -$51376.0 in 2026.
- Business Quant data shows CPHI's Other Working Capital Changes at -$51376.0 in Q1 2026, -$48019.0 in Q1 2025, and $139322.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 3.98 Mn |
| Dec 31, 2014 | 3.98 Mn |
| Dec 31, 2014 | 3.98 Mn |
| Sep 30, 2014 | -1.90 Mn |
| Sep 30, 2014 | -1.90 Mn |
| Sep 30, 2014 | -1.90 Mn |
| Jun 30, 2014 | 418,537.00 |
| Jun 30, 2014 | 418,537.00 |
| Jun 30, 2014 | 418,537.00 |
| Mar 31, 2014 | 11,461.00 |
| Mar 31, 2014 | 11,461.00 |
| Mar 31, 2014 | 11,461.00 |
| Sep 30, 2013 | 5,586.00 |
| Sep 30, 2013 | 5,586.00 |
| Sep 30, 2013 | 5,586.00 |
| Jun 30, 2013 | -693,094.00 |
| Jun 30, 2013 | -693,094.00 |
| Jun 30, 2013 | -693,094.00 |
| Mar 31, 2013 | 44,658.00 |
| Mar 31, 2013 | 44,658.00 |